ETBIOTCHealthcare · Medical - Pharmaceuticals

Eastgate Biotech Corp.

$0.00+0.00%(+$0.00)

TickerSpark Score

24/100

Poor

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ETBI research report →

52-Week Range20% of range

Low $0.00

Current $0.00

High $0.00

Companywww.EastGateBiotech.com

EastGate Biotech Corp. is a pharmaceutical company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body.

CEO: Rosella C. Perri
IPO: 2014
Employees: 2
HQ: Toronto, NV, US

Price Chart

-75.00% · this period

Valuation

Market Cap: $2.06M
P/E: -0.54
P/S: 20.63
P/B: -0.20
EV/EBITDA: -2.11
Div Yield: 0.00%

Profitability

Gross Margin: -110.37%
Op Margin: -3282.39%
Net Margin: -3553.67%
ROE: 40.71%
ROIC: 63.23%

Growth & Income

Revenue: $99.73K · -26.73%
Net Income: $-3,544,249 · -136.63%
EPS: $-0.00 · -58.33%
Op Income: $-3,273,690
FCF YoY: 123.31%

Performance & Tape

52W High: $0.00
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: 3.42
Avg Volume: 688

Get TickerSpark's AI analysis on ETBI

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Jan 15, 15	PERRI ROSE C	officer: President	other	0	—
Jan 15, 15	PERRI ROSE C	officer: President	other	0	—
Jan 5, 15	PERRI ROSE C	officer: President	other	1,036,475	$41.46K
Nov 9, 14	PERRI ROSE C	officer: President	other	320,400	$80.10K
Jan 5, 15	GLUSKIN ANNA E	director	buy	1,243,750	$49.75K
Jan 5, 15	GLUSKIN ANNA E	director	buy	1,243,750	$49.75K